Jazz Pharmaceuticals Fair Value
JA
The fair market value of JAZZ stock is 133.53 USD. Relative to the market price of 110.45 USD Jazz Pharmaceuticals is undervalued by 20.9%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Jazz Pharmaceuticals Valuation
Current JAZZ share ticker price is 110.45 USD.
The fair value level of 133.53 USD can be considered as an effective entry point for long-term investors to start investing in JAZZ stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 21% lower its fair value
Current price is 9% higher its minimum value
Current price is 480% lower its maximum value
Market price:
JAZZ stock is undervalued
It means the current price may concern as a Moderate Risk Entry Point
Jazz Pharmaceuticals PLC Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
102.28
2
Median P/E over 5 years
21.33
3
Minimum P/E over 5 years
16.14
4
Earning per share (last 12 months)
6.26 USD
Maximum value
1
x
4
=
640.2 USD
Fair value
2
x
4
=
133.53 USD
Minimum value
3
x
4
=
100.99 USD
Jazz Pharmaceuticals PLC price metrics
-2.49
Annual return (geometric mean)
32.66
Risk (standard deviation) of returns
β
0.54
Beta (volatility compared to market)